Unicycive gets second CRL for kidney drug as manufacturing woes continue

June 30, 2026 08:55 AM EDT PharmaFDA+Manufacturing Uni­cy­cive gets sec­ond CRL for kid­ney drug as man­u­fac­tur­ing woes con­tin­ue Anna Brown News Reporter Uni­cy­cive Ther­a­peu­tics’ chron­ic kid­ney dis­ease drug was re­ject­ed by the FDA for a sec­ond time over per­sis­tent is­sues at a third-par­ty con­tract man­u­fac­tur­er. The com­pa­ny’s … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER